{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PPAR\u03b4", "adipogenesis", "berberine", "obesity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37511356", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "18"}], "Language": ["eng"], "ELocationID": ["11600", "10.3390/ijms241411600"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "14", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "18"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Berberine Reduces Lipid Accumulation in Obesity via Mediating Transcriptional Function of PPAR\u03b4.", "Abstract": {"AbstractText": ["Obesity is defined as a dampness-heat syndrome in traditional Chinese medicine. Coptidis Rhizoma is an herb used to clear heat and eliminate dampness in obesity and its complications. Berberine (BBR), the main active compound in Coptidis Rhizoma, shows anti-obesity effects. Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor proteins that regulate the expression of genes involved in energy metabolism, lipid metabolism, inflammation, and adipogenesis. However, whether PPARs are involved in the anti-obesity effect of BBR remains unclear. As such, the aim of this study was to elucidate the role of PPARs in BBR treatment on obesity and the underlying molecular mechanisms. Our data showed that BBR produced a dose-dependent regulation of the levels of PPAR\u03b3 and PPAR\u03b4 but not PPAR\u03b1. The results of gene silencing and specific antagonist treatment demonstrated that PPAR\u03b4 is key to the effect of BBR. In 3T3L1 preadipocytes, BBR reduced lipid accumulation; in high-fat-diet (HFD)-induced obese mice, BBR reduced weight gain and white adipose tissue mass and corrected the disturbed biochemical parameters, including lipid levels and inflammatory and oxidative markers. Both the in vitro and in vivo efficacies of BBR were reversed by the presence of a specific antagonist of PPAR\u03b4. The results of a mechanistic study revealed that BBR could activate PPAR\u03b4 in both 3T3L1 cells and HFD mice, as evidenced by the significant upregulation of PPAR\u03b4 endogenous downstream genes. After activating by BBR, the transcriptional functions of PPAR\u03b4 were invoked, exhibiting negative regulation of CCAAT/enhancer-binding protein \u03b1 (Cebp\u03b1) and Ppar\u03b3 promoters and positive mediation of heme oxygenase-1 (Ho-1) promoter. In summary, this is the first report of a novel anti-obesity mechanism of BBR, which was achieved through the PPAR\u03b4-dependent reduction in lipid accumulation."]}, "AuthorList": [{"Identifier": ["0000-0002-2274-6802"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Shou", "ForeName": "Jia-Wen", "Initials": "JW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants and Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Shaw", "ForeName": "Pang-Chui", "Initials": "PC"}], "GrantList": [{"GrantID": "PF15-16899", "Agency": "Hong Kong Ph.D. Fellowship Scheme, Research Grants Council of Hong Kong", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "PPAR delta"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "PPAR delta"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": [], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["metabolism"], "DescriptorName": "PPAR gamma"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Obesity"}, {"QualifierName": [], "DescriptorName": "Lipids"}, {"QualifierName": ["genetics"], "DescriptorName": "Lipid Metabolism"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lobstein T., Brinsden H., Neveux M. World Obesity Atlas 2022. World Obesity Federation; London, UK: 2022."}, {"Citation": "Hruby A., Hu F.B. The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2015;33:673\u2013689. doi: 10.1007/s40273-014-0243-x.", "ArticleIdList": ["10.1007/s40273-014-0243-x", "PMC4859313", "25471927"]}, {"Citation": "Clemmensen C., Petersen M.B., Sorensen T.I.A. Will the COVID-19 pandemic worsen the obesity epidemic? Nat. Rev. Endocrinol. 2020;16:469\u2013470. doi: 10.1038/s41574-020-0387-z.", "ArticleIdList": ["10.1038/s41574-020-0387-z", "PMC7342551", "32641837"]}, {"Citation": "Popkin B.M., Du S.F., Green W.D., Beck M.A., Algaith T., Herbst C.H., Alsukait R.F., Alluhidan M., Alazemi N., Shekar M. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes. Rev. 2020;21:e13128. doi: 10.1111/obr.13128.", "ArticleIdList": ["10.1111/obr.13128", "PMC7461480", "32845580"]}, {"Citation": "Heymsfield S.B., Wadden T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl. J. Med. 2017;376:254266. doi: 10.1056/NEJMra1514009.", "ArticleIdList": ["10.1056/NEJMra1514009", "28402780"]}, {"Citation": "Wadden T.A., Tronieri J.S., Butryn M.L. Lifestyle modification approaches for the treatment of obesity in adults. Am. Psychol. 2020;75:235\u2013251. doi: 10.1037/amp0000517.", "ArticleIdList": ["10.1037/amp0000517", "PMC7027681", "32052997"]}, {"Citation": "Wadden T.A., Webb V.L., Moran C.H., Bailer B.A. Lifestyle modification for obesity: New developments in diet, physical activity, and behavior therapy. Circulation. 2012;125:1157\u20131170. doi: 10.1161/CIRCULATIONAHA.111.039453.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.111.039453", "PMC3313649", "22392863"]}, {"Citation": "M\u00fcller T.D., Bl\u00fcher M., Tsch\u00f6p M.H., DiMarchi R.D. Anti-obesity drug discovery: Advances and challenges. Nat. Rev. Drug Discov. 2022;21:201\u2013223. doi: 10.1038/s41573-021-00337-8.", "ArticleIdList": ["10.1038/s41573-021-00337-8", "PMC8609996", "34815532"]}, {"Citation": "Pilitsi E., Farr O.M., Polyzos S.A., Perakakis N., Nolen-Doerr E., Papathanasiou A.-E., Mantzoros C.S. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism. 2019;92:170\u2013192. doi: 10.1016/j.metabol.2018.10.010.", "ArticleIdList": ["10.1016/j.metabol.2018.10.010", "30391259"]}, {"Citation": "Tak Y.J., Lee S.Y. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Curr. Obes. Rep. 2021;10:14\u201330. doi: 10.1007/s13679-020-00422-w.", "ArticleIdList": ["10.1007/s13679-020-00422-w", "PMC7787121", "33410104"]}, {"Citation": "Arterburn D.E., Telem D.A., Kushner R.F., Courcoulas A.P. Benefits and Risks of Bariatric Surgery in Adults: A Review. JAMA. 2020;324:879\u2013887. doi: 10.1001/jama.2020.12567.", "ArticleIdList": ["10.1001/jama.2020.12567", "32870301"]}, {"Citation": "Gagnon C., Schafer A.L. Bone Health After Bariatric Surgery. JBMR Plus. 2018;2:121\u2013133. doi: 10.1002/jbm4.10048.", "ArticleIdList": ["10.1002/jbm4.10048", "PMC6124196", "30283897"]}, {"Citation": "van Beek A.P., Emous M., Laville M., Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: Pathophysiology, diagnosis, and management. Obes. Rev. 2017;18:68\u201385. doi: 10.1111/obr.12467.", "ArticleIdList": ["10.1111/obr.12467", "27749997"]}, {"Citation": "Stienstra R., Duval C., Muller M., Kersten S. PPARs, Obesity, and Inflammation. PPAR Res. 2007;2007:95974. doi: 10.1155/2007/95974.", "ArticleIdList": ["10.1155/2007/95974", "PMC1783744", "17389767"]}, {"Citation": "Berger J.P., Akiyama T.E., Meinke P.T. PPARs: Therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 2005;26:244\u2013251. doi: 10.1016/j.tips.2005.03.003.", "ArticleIdList": ["10.1016/j.tips.2005.03.003", "15860371"]}, {"Citation": "Hong F., Pan S., Guo Y., Xu P., Zhai Y. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism. Molecules. 2019;24:2545. doi: 10.3390/molecules24142545.", "ArticleIdList": ["10.3390/molecules24142545", "PMC6680900", "31336903"]}, {"Citation": "Zhang C.-H., Sheng J.-Q., Xie W.-H., Luo X.-Q., Xue Y.-N., Xu G.-L., Chen C. Mechanism and Basis of Traditional Chinese Medicine Against Obesity: Prevention and Treatment Strategies. Front. Pharmacol. 2021;12:615895. doi: 10.3389/fphar.2021.615895.", "ArticleIdList": ["10.3389/fphar.2021.615895", "PMC7982543", "33762940"]}, {"Citation": "Wang J., Wang L., Lou G., Zeng H.-R., Hu J., Huang Q., Peng W., Yang X.-B. Coptidis Rhizoma: A comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm. Biol. 2019;57:193\u2013225. doi: 10.1080/13880209.2019.1577466.", "ArticleIdList": ["10.1080/13880209.2019.1577466", "PMC6461078", "30963783"]}, {"Citation": "Ji Y., Luo K., Zhang J.M., Ni P., Xiong W., Luo X., Xu G., Liu H., Zeng Z. Additional file 1 of Obese rats intervened with Rhizoma coptidis revealed differential gene expression and microbiota by serum metabolomics. BMC Complement. Med. 2021;21:208. doi: 10.6084/m9.figshare.15153835.", "ArticleIdList": ["10.6084/m9.figshare.15153835", "PMC8359625", "34380455"]}, {"Citation": "Huang Y., Wang L., Wang S., Cai F., Zheng G., Lu A., Yu X., Jiang M. Treatment Principles of Obesity with Chinese Herbal Medicine: Literature Analysis by Text Mining. Engineering. 2013;5:7\u201311. doi: 10.4236/eng.2013.510B002.", "ArticleIdList": ["10.4236/eng.2013.510B002"]}, {"Citation": "Xie W., Gu D., Li J., Cui K., Zhang Y. Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice. PLoS ONE. 2011;6:e24520. doi: 10.1371/journal.pone.0024520.", "ArticleIdList": ["10.1371/journal.pone.0024520", "PMC3167861", "21915347"]}, {"Citation": "Park H.-J., Jung E., Shim I. Berberine for Appetite Suppressant and Prevention of Obesity. BioMed Res. Int. 2020;2020:3891806. doi: 10.1155/2020/3891806.", "ArticleIdList": ["10.1155/2020/3891806", "PMC7752296", "33415147"]}, {"Citation": "Zhang Z., Zhang H., Li B., Meng X., Wang J., Zhang Y., Yao S., Ma Q., Jin L., Yang J., et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat. Commun. 2014;5:5493. doi: 10.1038/ncomms6493.", "ArticleIdList": ["10.1038/ncomms6493", "25423280"]}, {"Citation": "Hu Y., Davies G.E. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia. 2010;81:358\u2013366. doi: 10.1016/j.fitote.2009.10.010.", "ArticleIdList": ["10.1016/j.fitote.2009.10.010", "19861153"]}, {"Citation": "Yu H., Li C., Yang J., Zhang T., Zhou Q. Berberine is a potent agonist of peroxisome proliferator activated receptor alpha. Front. Biosci. 2016;21:1052\u20131060.", "ArticleIdList": ["27100490"]}, {"Citation": "Shou J.W., Li X.X., Tang Y.S., Lim-Ho Kong B., Wu H.Y., Xiao M.J., Cheung C.K., Shaw P.C. Novel mechanistic insight on the neuroprotective effect of berberine: The role of PPARdelta for antioxidant action. Free Radic. Biol. Med. 2022;181:62\u201371. doi: 10.1016/j.freeradbiomed.2022.01.022.", "ArticleIdList": ["10.1016/j.freeradbiomed.2022.01.022", "35093536"]}, {"Citation": "Xu Y., Yu T., Ma G., Zheng L., Jiang X., Yang F., Wang Z., Li N., He Z., Song X., et al. Berberine modulates deacetylation of PPARgamma to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway. Int. J. Biol. Sci. 2021;17:3173\u20133187. doi: 10.7150/ijbs.62556.", "ArticleIdList": ["10.7150/ijbs.62556", "PMC8375237", "34421358"]}, {"Citation": "Hu Y., Davies G. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation. Phytomedicine. 2009;16:864\u2013873. doi: 10.1016/j.phymed.2009.03.002.", "ArticleIdList": ["10.1016/j.phymed.2009.03.002", "19403287"]}, {"Citation": "Wang C., Wang Y., Ma S.-R., Zuo Z.-Y., Wu Y.-B., Kong W.-J., Wang A.-P., Jiang J.-D. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci. Rep. 2019;9:13415. doi: 10.1038/s41598-019-50103-5.", "ArticleIdList": ["10.1038/s41598-019-50103-5", "PMC6746795", "31527742"]}, {"Citation": "Deng Y., Tang K., Chen R., Nie H., Liang S., Zhang J., Zhang Y., Yang Q. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway. Exp. Ther. Med. 2019;17:2091\u20132098. doi: 10.3892/etm.2019.7208.", "ArticleIdList": ["10.3892/etm.2019.7208", "PMC6396022", "30867696"]}, {"Citation": "Huang C., Zhang Y., Gong Z., Sheng X., Li Z., Zhang W., Qin Y. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem. Biophys. Res. Commun. 2006;348:571\u2013578. doi: 10.1016/j.bbrc.2006.07.095.", "ArticleIdList": ["10.1016/j.bbrc.2006.07.095", "16890192"]}, {"Citation": "Sun S., Yang Y., Xiong R., Ni Y., Ma X., Hou M., Chen L., Xu Z., Chen L., Ji M. Oral berberine ameliorates high-fat diet-induced obesity by activating TAS2Rs in tuft and endocrine cells in the gut. Life Sci. 2022;311 Pt A:121141. doi: 10.1016/j.lfs.2022.121141.", "ArticleIdList": ["10.1016/j.lfs.2022.121141", "36341914"]}, {"Citation": "Zhang X., Zhao Y., Xu J., Xue Z., Zhang M., Pang X., Zhang X., Zhao L. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci. Rep. 2015;5:14405. doi: 10.1038/srep14405.", "ArticleIdList": ["10.1038/srep14405", "PMC4585776", "26396057"]}, {"Citation": "Xu J.H., Liu X.Z., Pan W., Zou D.J. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Mol. Med. Rep. 2017;15:2765\u20132787. doi: 10.3892/mmr.2017.6321.", "ArticleIdList": ["10.3892/mmr.2017.6321", "PMC5428400", "28447763"]}, {"Citation": "Evans R.M., Barish G.D., Wang Y.-X. PPARs and the complex journey to obesity. Nat. Med. 2004;10:355\u2013361. doi: 10.1038/nm1025.", "ArticleIdList": ["10.1038/nm1025", "15057233"]}, {"Citation": "Zhou J.Y., Zhou S.W., Bin Zhang K., Tang J.L., Guang L.X., Ying Y., Xu Y., Zhang L., Li D.D. Chronic Effects of Berberine on Blood, Liver Glucolipid Metabolism and Liver PPARs Expression in Diabetic Hyperlipidemic Rats. Biol. Pharm. Bull. 2008;31:1169\u20131176. doi: 10.1248/bpb.31.1169.", "ArticleIdList": ["10.1248/bpb.31.1169", "18520050"]}, {"Citation": "Zhou J., Zhou S. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes. Eur. J. Pharmacol. 2010;649:390\u2013397. doi: 10.1016/j.ejphar.2010.09.030.", "ArticleIdList": ["10.1016/j.ejphar.2010.09.030", "20868663"]}, {"Citation": "Shou J.W., Shaw P.C. Berberine activates PPARdelta and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma. Phytomedicine. 2023;115:154842. doi: 10.1016/j.phymed.2023.154842.", "ArticleIdList": ["10.1016/j.phymed.2023.154842", "37148713"]}, {"Citation": "Dickey A.S., Sanchez D.N., Arreola M., Sampat K.R., Fan W., Arbez N., Akimov S., Van Kanegan M.J., Ohnishi K., Gilmore-Hall S.K., et al. PPARdelta activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis. Sci. Transl. Med. 2017;9:eaal2332. doi: 10.1126/scitranslmed.aal2332.", "ArticleIdList": ["10.1126/scitranslmed.aal2332", "PMC5748332", "29212711"]}, {"Citation": "Adhikary T., Wortmann A., Schumann T., Finkernagel F., Lieber S., Roth K., Toth P.M., Diederich W.E., Nist A., Stiewe T., et al. The transcriptional PPARbeta/delta network in human macrophages defines a unique agonist-induced activation state. Nucleic Acids Res. 2015;43:5033\u20135051. doi: 10.1093/nar/gkv331.", "ArticleIdList": ["10.1093/nar/gkv331", "PMC4446423", "25934804"]}, {"Citation": "Zhang J., Tang H., Deng R., Wang N., Zhang Y., Wang Y., Liu Y., Li F., Wang X., Zhou L. Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity. PLoS ONE. 2015;10:e0125667. doi: 10.1371/journal.pone.0125667.", "ArticleIdList": ["10.1371/journal.pone.0125667", "PMC4415922", "25928058"]}, {"Citation": "Jang J., Jung Y., Seo S.J., Kim S.-M., Shim Y.J., Cho S.H., Chung S.-I., Yoon Y. Berberine activates AMPK to suppress proteolytic processing, nuclear translocation and target DNA binding of SREBP-1c in 3T3-L1 adipocytes. Mol. Med. Rep. 2017;15:4139\u20134147. doi: 10.3892/mmr.2017.6513.", "ArticleIdList": ["10.3892/mmr.2017.6513", "PMC5436149", "28487951"]}, {"Citation": "Zhou L., Wang X., Yang Y., Wu L., Li F., Zhang R., Yuan G., Wang N., Chen M., Ning G. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Biochim. Et Biophys. Acta. 2011;1812:527\u2013535. doi: 10.1016/j.bbadis.2010.10.001.", "ArticleIdList": ["10.1016/j.bbadis.2010.10.001", "20969954"]}, {"Citation": "Zebisch K., Voigt V., Wabitsch M., Brandsch M. Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal. Biochem. 2012;425:88\u201390. doi: 10.1016/j.ab.2012.03.005.", "ArticleIdList": ["10.1016/j.ab.2012.03.005", "22425542"]}, {"Citation": "Liu J., Hao W., He Z., Kwek E., Zhao Y., Zhu H., Liang N., Ma K.Y., Lei L., He W.-S., et al. Beneficial effects of tea water extracts on the body weight and gut microbiota in C57BL/6J mice fed with a high-fat diet. Food Funct. 2019;10:2847\u20132860. doi: 10.1039/C8FO02051E.", "ArticleIdList": ["10.1039/C8FO02051E", "31062778"]}, {"Citation": "Shou J.-W., Cheung C.-K., Gao J., Shi W.-W., Shaw P.-C. Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation. Front. Cell. Neurosci. 2019;13:395. doi: 10.3389/fncel.2019.00395.", "ArticleIdList": ["10.3389/fncel.2019.00395", "PMC6733922", "31551713"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "19"}, {"Year": "2023", "Month": "7", "Day": "13"}, {"Year": "2023", "Month": "7", "Day": "17"}, {"Year": "2023", "Month": "7", "Day": "31", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "51"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "23"}, {"Year": "2023", "Month": "7", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37511356", "PMC10380538", "10.3390/ijms241411600", "ijms241411600"]}}], "PubmedBookArticle": []}